section name header

Y-Site Injection Compatibility (1:1 Mixture)

Doxorubicin HCl

(Mfr: PH)(Conc: 2 mg/mL)

I

TPN #212 to #215e

Remarks:

Substantial loss of natural subvisible haze occurs immediately

Ref:

2109